The Lab-on-a-chip and Microarrays (Biochip) Market, estimated at USD 22,203.5 Mn in 2025, is expected to exhibit a CAGR of 13.43% and reach USD 53,643.5 Mn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
Among type, lab-on-a-chip segment held dominant position in the global lab-on-a-chip and microarrays (biochip) market in 2022, accounting for 72.4% share in terms of value, increasing approval and launch of new products is expected to propel growth of the segment during the forecast period.
Market Trends:
Technological advancements is one of the key trends expected to propel the growth of the global lab-on-a-chip and microarrays (biochip) market. A lab-on-a-chip could enable healthcare providers to open up diagnosis to a wider population and provide appropriate treatment to those who really need it, without the use of rare and expensive drugs. Moreover, players in the market as well as several governments worldwide are increasingly investing in lab-on-a-chip, as this technology is expected to change daily lives people over the forecast period. This trend is expected to continue over the forecast period, driving the growth of the market.